ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
0.97
0.12 (14.12%)
At close: Jun 17, 2025, 11:51 AM
ImmunoPrecise Antibodies Revenue Breakdown
| Period Ending | Apr 30, 2024 | Apr 30, 2023 | Apr 30, 2022 |
|---|---|---|---|
| Product Sales Revenue | 2.04M | 1.75M | 1.65M |
| Product Sales Revenue Growth | +16.49% | +5.75% | n/a |
| Project Revenue Revenue | 22.23M | 18.68M | 17.36M |
| Project Revenue Revenue Growth | +19.05% | +7.61% | n/a |
Revenue by Geography
| Period Ending | Apr 30, 2024 | Apr 30, 2023 | Apr 30, 2022 |
|---|---|---|---|
| Australia Revenue | 482K | 630K | 1.54M |
| Australia Revenue Growth | -23.49% | -59.09% | n/a |
| All Other Countries Revenue | 224K | 602K | 1.01M |
| All Other Countries Revenue Growth | -62.79% | -40.22% | n/a |
| Canada Revenue | 389K | 618K | 572K |
| Canada Revenue Growth | -37.06% | +8.04% | n/a |
| Europe Revenue | 10.87M | 9.45M | 9.43M |
| Europe Revenue Growth | +14.99% | +0.22% | n/a |
| United States Revenue | 12.56M | 9.37M | 6.82M |
| United States Revenue Growth | +34.07% | +37.40% | n/a |
Operating Expense Breakdown
| Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Aug 9, 2023 | Apr 30, 2023 | Jan 31, 2023 | Dec 13, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.9M | 4.51M | 4.65M | 5.03M | 4.83M | 4.23M | 5.05M | 3.78M | 4.95M | 4.65M | 5.25M | 4.81M | 4.17M | 3.71M | 4.04M | 4.53M | 3.88M | 2.91M | 2.02M | 2.83M | 1.06M | 2.17M | 1.97M | 2.57M | 2.05M | 2.14M | 2M | 1.76M | 1.87M | 1.23M | 681.01K | 1.14M | 698.4K | 241.22K | 370.34K | 4.11K | 14.74K | 2.75K | 5.01K | 8.18K |
| Selling, General, and Administrative Revenue Growth | +8.74% | -2.93% | -7.60% | +4.16% | +14.14% | -16.26% | +33.63% | -23.63% | +6.45% | -11.53% | +9.23% | +15.46% | +12.14% | -8.16% | -10.71% | +16.78% | +33.21% | +44.30% | -28.77% | +167.52% | -51.27% | +10.47% | -23.55% | +25.70% | -4.30% | +6.79% | +14.00% | -5.99% | +52.57% | +79.88% | -40.26% | +63.23% | +189.52% | -34.86% | +8919.43% | -72.15% | +436.15% | -45.13% | -38.74% | n/a |
| Research and Development Revenue | 1.06M | 1.16M | 1.64M | 927K | 1M | 1.04M | 947K | 919K | 1.56M | 5M | 6.18M | 1.33M | 2.06M | 3.04M | 1.12M | 615.47K | n/a | 1.05M | 309.21K | -221K | 54.19K | 445.84K | 167.26K | 188.65K | 60.05K | 19.27K | 31.79K | 385.5K | 64.68K | 118.93K | 106.32K | 393.92K | 72.89K | n/a | 59.22K | 417.7K | 59.55K | n/a | n/a | n/a |
| Research and Development Revenue Growth | -8.48% | -29.66% | +77.13% | -7.39% | -3.47% | +9.50% | +3.05% | -41.20% | -68.75% | -19.13% | +364.69% | -35.33% | -32.39% | +172.03% | +81.81% | n/a | -100.00% | +239.25% | -239.92% | -507.82% | -87.85% | +166.56% | -11.34% | +214.16% | +211.68% | -39.39% | -91.75% | +495.99% | -45.61% | +11.86% | -73.01% | +440.41% | n/a | -100.00% | -85.82% | +601.39% | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 1.31M | 1.24M | 718K | 909K | 649K | 921K | 1.06M | 934K | 836K | 817K | 1.02M | 151K | 228K | 198K | 163K | 186.19K | 215.9K | 255.6K | 33.31K | 151.46K | 48.12K | 60.95K | 117.2K | 139.32K | 357.29K | 268.88K | 53.77K | 19.2K | 36.38K | 46.1K | 33K | 92.87K | 17.43K | 4.89K | 4K | 4.3K | 7.12K | 5.5K | 3.91K | n/a |
| Sales and Marketing Revenue Growth | +5.90% | +72.28% | -21.01% | +40.06% | -29.53% | -13.36% | +13.81% | +11.72% | +2.33% | -20.06% | +576.82% | -33.77% | +15.15% | +21.47% | -12.46% | -13.76% | -15.53% | +667.43% | -78.01% | +214.78% | -21.05% | -47.99% | -15.88% | -61.01% | +32.88% | +400.06% | +180.11% | -47.24% | -21.08% | +39.70% | -64.47% | +432.92% | +256.31% | +22.27% | -7.02% | -39.54% | +29.29% | +40.74% | n/a | n/a |